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Effects of uremic ultrafiltrate on the regulation of the parathy- Uremic patients develop progressive parathyroid hyper-
roid cell cycle by calcitriol. plasia as a consequence of a decrease in the serum con-
Background. Calcitriol (CTR) is used in the treatment of centration of calcium and calcitriol and a rise in serum
hyperparathyroidism secondary to renal failure because it de-
phosphate levels. All these factors together stimulate para-creases parathyroid hormone (PTH) synthesis and parathyroid
thyroid cell proliferation. At some time point during thecell proliferation. Previous studies in tissues other than parathy-
development of parathyroid hyperplasia, there is mono-roids have demonstrated that uremic factors affect the action
of CTR on the target cells. We questioned whether the uremic clonal transformation of parathyroid cells and these cells
milieu interferes with the inhibition of parathyroid cell prolifer- exihibit a decreased expression of receptors for vitamin D
ation by CTR. and calcium. This explains, at least in part, the poor control
Methods. Studies were performed in vitro using freshly ex-
of parathyroid cell proliferation by vitamin D and calciumcised normal dog parathyroid tissue incubated for 24 hours
in patients with advanced secondary hyperparathyroidism,with and without CTR and in the presence of either total
which is characterized by parathyroid nodular hyperpla-uremic ultrafiltrate (UUF) from uremic patients or high-pres-
sure liquid chromatography (HPLC)-derived fractions (hydro- sia [1]. Calcitriol is a primary inhibitor of parathyroid
philic compounds eluting early and hydrophobic compounds cell proliferation by acting on the gene expression of the
eluting late) of this UUF (F1 to F4). Parathyroid cell prolifera- cell cycle regulator c-myc [2]. However, our recent in
tion was assessed by flow cytometry.
vitro study showed that the hyperplastic parathyroid tis-Results. The addition of CTR 108 and 107 mol/L to para-
sue from patients with advanced secondary hyperpara-thyroid tissue produced an inhibition of the proliferation that
thyroidism has a poor response to calcitriol, as a high dosewas prevented in the presence of UUF. In a medium containing
CTR 108 mol/L, the addition of F1, F2 and F3, but not F4, of calcitriol was required to inhibit cell proliferation [3].
prevented the CTR-induced inhibition of parathyroid cell pro- These findings could be explained by a decreased VDR
liferation. With CTR 107 mol/L, the inhibition of proliferation expression in advanced parathyroid hyperplasia [4].
was observed even in the presence of F1, F2 and also F4, but Several reports have shown that uremic plasma con-was prevented by F3. Uric acid (7 mg/dL), indoxyl sulfate (5
tains substances that interfere with the action of vitaminmg/dL) and p-cresol (1.4 mg/dL), which coeluted with F1, F2
D; preincubation of intestinal VDR with uremic ultrafil-and F4, respectively, did not interfere with the inhibitory action
of CTR 107 mol/L; however, the addition of phenol (0.14 trate significantly reduced the interaction of the VDR-
mg/dL), which coeluted with F3, prevented the CTR-induced hormone complex with DNA [5–7]. However, these stud-
inhibition of parathyroid cell proliferation. ies did not evaluate the effect of uremic ultrafiltrate on
Conclusions. The presence of uremic toxins prevents the parathyroid cells.inhibition of parathyroid cell proliferation induced by calcitriol.
The presence of uremic substances potentially affects
the regulation of parathyroid cell proliferation by calci-
triol. Therefore, we considered it important to determine
whether there is an independent effect of uremic toxins
on the regulation of parathyroid cell proliferation by cal-1 Present address: Department of Environmental Biology and Public
citriol. The experiments were performed in vitro to avoidHealth, University of Huelva, Spain.
confounding effects derived from calcitriol administra-
Key words: uremia, ultrafiltrate, parathyroid, proliferation, calcitriol, tion such as changes in serum calcium and phosphate.vitamin D, cell cycle regulation.
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of age) from the City Animal Control Service. These electrode (634 Ca/pH analyzer; Ciba Corning, Essex,
dogs were individually housed during a period of 20 days UK). Ionized calcium concentration also was measured
awaiting adoption. During this time the dogs were fed in each well after the completion of the experiment and
a 1.2% calcium and 0.8% phosphorus diet containing no change in the ionized calcium concentration was ob-
1600 IU per kg of vitamin D. At euthanization, the two served. The parathyroid tissue was cultured for 24 hours
superior parathyroid glands were excised and maintained in media without UUF (control) or containing total
in culture medium at 4C until the experiments were UUF, F1, F2, F3 or F4, with and without calcitriol (CTR)
performed. The parathyroidectomy required less than 108 or 107 mol/L. Additional studies were carried out
five minutes. to evaluate the effect of specific uremic toxins at the same
concentration contained in the uremic serum: uric acidPreparation of UUF and the HPLC-derived fractions
(final concentration 7 mg/dL), indoxyl sulfate (5 mg/dL),
Uremic fractions were prepared as previously reported phenol (0.14 mg/dL) and p-cresol (1.4 mg/dL), as these
[8]. Uremic ultrafiltrate (UUF) was pooled from nine compounds coeluted whithin F1, F2, F3 and F4, respec-
patients with chronic hemodialysis (with high-flux poly- tively. The experimental procedure was as previously
sulfone dialyzers, Rapido BLS 627, high permeability described for the uremic fractions.
membranes; Sorin-Bellco, Mirandola, Italy). Ultrafiltrate
was collected at the beginning of the hemodialysis ses- Flow cytometry
sion and filtered through a 0.2 m filter (Minisart NML;
Cell proliferation was quantified by flow cytometry;Sartorius GmbH, Go¨ttingen, Germany). Each 5 mL of
this required isolation of cells that were obtained fromUUF was separated by semipreparative, reversed phase
the small pieces of parathyroid tissue used in each experi-high-performance liquid chromatography (HPLC) using
mental test period. Small pieces of parathyroid tissuea 10-m Rsil C18 column (250 10 mm; BioRad Labora-
were viewed under an inverted microscope (10) andtories S.A.-N.V., Nazareth Eke, Belgium) at a low flow
were gently stripped apart using a sharp Dumont forceps.rate of 3 mL/min, with a linear gradient of 50 mmol/L
This was followed by gentle pipetting. To maintain highammonium formate, pH 4.0, from 100% to 0%, and of
cell concentrations, these manipulations were performedmethanol from 0% to 100% over 60 minutes. This ap-
in a small volume (50 L) of phosphate-buffered salineproach resulted in a separation of hydrophilic com-
(PBS). The cell cycle was analyzed by a method describedpounds eluting early during the chromatography and hy-
by Vindelov and Christensen [9]. Dispersed cells weredrophobic compounds eluting late. HPLC peaks were
first treated with PBS containing 0.8% Triton X-100 atdetected by monitoring of ultraviolet absorption at 254
nm (UVICORD SII; Pharmacia, Bromma, Sweden). 37C, then with DNAase free RNAase, 10 g/mL for 10
Total UUF was reconstituted from the HPLC fractions minutes, and finally with propidium iodide, 20 g/mL for
collected after the first eight minutes of the chromatogra- 30 minutes at 37C in the dark. Cells were immediately
phy, omitting the dead volume and the salt-containing acquired by the flow cytometer (FACScan; Becton-Dickin-
fraction. We tested fractions (F) collected from 9 to 16 son, San Jose CA, USA). LYSYS II and CELLFIT soft-
(F1), 17 to 24 (F2), 25 to 40 (F3), and 41 to 60 (F4) ware with doublet discrimination module (DDM; Becton-
minutes. The eluates were lyophilized and reconstituted Dickinson) were used for data acquisition and analysis,
in 5 mL of the culture medium. respectively. Cell debris and clumps were excluded from
analysis by gating. This method measures the percent ofIncubation conditions
cells in the different phases of the cell cycle: cells in
Experiments were performed using parathyroid tissue G0/G1 phase are diploid cells; cells in phase S show anslices instead of dispersed parathyroid cells, so that tissue increase in the synthesis of DNA which precedes cell
architecture was maintained. Parathyroid glands were
duplication and cells in G2M have doubled the DNAcut into small pieces of approximately 1 mm3 and placed
content. The percent of cells in the S phase was used asin individual wells (24 well dishes from Nunclon Delta
a marker of cell proliferationSI, InterMed, Denmark) with constant shaking at 37C
and placed in an incubator with a humid atmosphere. Reagents
The incubation medium was buffered (pH 7.4) and con-
These included PBS (Oxoid, Hampshire, UK) and cal-tained in mmol/L: NaCl 125, KCl 5.9, MgCl2 0.5, NaH2PO4
citriol (Abbott, Madrid, Spain). Uric acid, indoxyl sulfate,and Na2HPO4 1 (1:2 ratio), Na-pyruvate 1, glutamine 4,
phenol, p-cresol, sodium lauril sarkosinate, proteinase K,glucose 12 and Hepes 25. Insulin 0.1 IU/mL, bovine
RNAase, Triton X-100, DNAase free RNAase, propid-serum albumin 0.1%, penicillin G 100 IU/mL, and strep-
ium iodide, Nonidet-P40, trypsin, trypsin inhibitor andtomycin 100 g/mL were added to the medium. CaCl2
spermine were obtained from Sigma Chemical Co. (St.was added to achieve a final target ionized calcium con-
centration of 1.25 mmol/L as measured with a selective Louis, MO, USA).
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Fig. 1. Effects of total uremic ultrafiltrate (UUF) and the high-perfor-
mance liquid chromatography (HPLC)-derived fractions (F1 to F4)
after 24 hours of incubation on parathyroid cell proliferation. Data
(mean  SE) show the percent of cells in the S phase of the cell cycle
(N  8).
Fig. 2. Effects of total uremic ultrafiltrate (Total UUF) on calcitriol
(108 and 107 mol/L)-induced inihbition of parathyroid cell prolifera-
tion after 24 hours of incubation. Data (mean  SE) show the percent
of cells in the S phase of the cell cycle (N  8; *P  0.01 vs. controlStatistical analysis
without calcitriol).
Differences between two means were evaluated by the
Wilcoxon test and comparisons of three or more means
were evaluated by ANOVA followed by the Duncan
derived fractions (F1 to F4) added to the 24-hour culturetest. Results are expressed as the mean  SE. Data are
medium with CTR 108 and 107 mol/L are shown inthe means of eight independent duplicated experiments.
Figure 3 A and B, respectively. In a medium containing
CTR 108 mol/L, fractions F1, F2 and F3 prevented the
RESULTS CTR-induced inhibition of parathyroid cell proliferation.
Effect of uremic ultrafiltrates on parathyroid However, in parathyroid tissue cultured with fraction
cell proliferation F4, the proportion of cells in S phase relative to control
(no CTR added) was reduced to 56%, which is similarStudies were performed in dog parathyroid tissue incu-
to the value obtained without the addition of any of thebated for 24-hours without CTR and in the presence of
UUF products (53%). Thus, fraction F4 did not appeartotal UUF and the HPLC-derived fractions (F1 to F4).
to interfere with the inhibition of parathyroid cell prolif-As shown in Figure 1, in control medium (without UUF),
eration induced by CTR.the percent of cells progressing to the S phase was 8.4 
A higher concentration of CTR, 107 mol/L, was able2.0%. Addition of total UUF or each HPLC-derived
to produce inhibition of parathyroid cell proliferation infractions, F1, F2, F3 and F4 did not affect significantly
the presence of fractions F1, F2 and also F4. Relative tothe rate of cell proliferation as compared with control.
control (no calcitriol added) the proportion of cells in S
Effect of UUF on CTR-induced inhibition of phase was reduced to 45% without UUF and 50%, 36%,
parathyroid cell proliferation 58% with fractions F1, F2 and F4, respectively. Even with
this high concentration of calcitriol, fraction F3 preventedTotal UUF. The addition of CTR 108 and 107 mol/L
a significant decrease in the percent of cells in S phase.to parathyroid tissue cultured for 24 hours without UUF
Specific toxins. Experiments were performed to evalu-produced a significant inhibition of parathyroid cell pro-
ate the effect of specific compounds on the inhibition ofliferation (Fig. 2).
parathyroid cell cycle by CTR 107 mol/L, which wasRelative to control (no CTR added), the proportion
the concentration that showed to better discriminate theof cells in the S phase was reduced to 54%, P  0.05
effect of the different fractions. The addition of uric acidand 44%, P  0.01 by 108 and 107 mol/L of CTR,
(7 mg/dL), indoxyl sulfate (5 mg/dL) and p-cresol (1.4respectively. By contrast, the percent cells in the S phase
mg/dL) to the medium, which coeluted with F1, F2 andin the parathyroid tissue incubated simultaneously with
F4, respectively, did not interfere the inhibitory action oftotal UUF and CTR were significantly different from
CTR 107 mol/L on parathyroid cell proliferation (Fig. 4).that incubated with CTR alone, and not different from
As compared to the control (without calcitriol), the per-the control without CTR. Thus, UUF decreased the abil-
cent cells in the S phase was reduced to 61%, P  0.01ity of CTR to inhibit parathyroid cell proliferation.
HPLC-derived fractions. Experiments with HPLC- for uric acid, 46%, P 0.01 for indoxyl sulfate and 62%,
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Fig. 4. Effects of specific uremic toxins on the inihbition of parathyroid
cell proliferation by calcitriol (107 mol/L) after 24 hours of incubation.
Uric acid (final concentration of 7 mg/dL), indoxyl sulfate (5 mg/dL),
phenol (0.14 mg/dL) and p-cresol (1.4 mg/dL), which coeluted with F1,
F2, F3 and F4, respectively, were analyzed. Data (mean  SE) show
the percent of cells in the S phase of the cell cycle (N  8; *P  0.01
vs. control without calcitriol).
the interaction of the CTR receptor (VDR) with the vita-
min D response elements (VDRE) of the DNA. Chronic
renal failure is often associated with an end-organ resis-
tance to the biologically active form of vitamin D, CTR.
Uremic plasma contains compounds, termed uremic tox-
ins, which could account for the diminished biological
response to CTR in renal failure, even with normal levels
of vitamin D. Uremic toxins have been reported to in-
hibit the DNA-binding capacity of the hormone-receptorFig. 3. Effects of the HPLC-derived fractions (F1 to F4) on the inhibi-
complex with the nuclear chromatin [5–7, 10]. This hastion of parathyroid cell proliferation by calcitriol 108 mol/L (A ) and
107 mol/L (B ) after 24 hours of incubation. Data (mean  SE) show been attributed to the formation of Schiff bases between
the percent of cells in the S phase of the cell cycle (N  8; *P  0.01 reactive aldehydes and lysine residues of the DNA do-vs. control without calcitriol).
main of VDR [7], but experiments on point mutagenesis
of the lysine residues could not confirm this hypothesis
[11]. A reduction in the VDR levels in the target cells
also has been involved in the diminished response toP  0.01 for p-cresol; these values were not statistically
CTR in renal failure [4]. Uremic toxins have been showndifferent from the 50% observed without uremic toxins
to reduce the biological action of calcitriol by suppressingplus CTR. However, addition of phenol (0.14 mg/dL),
receptor synthesis and the calcitriol induced up-regula-which coeluted with F3, prevented the CTR-induced in-
tion in the gut [10] and promielocytic leukemic cellshibition of parathyroid cell proliferation.
[12]. In addition, uremic toxins also may have an effect,
directly or through the impaired binding of the calctriol-
DISCUSSION receptor complex to chromatin, on the activity or the
The present work was designed to investigate whether synthesis of especific proteins involved in downstream
uremic toxins had an effect on the regulation of parathy- signaling pathways of calcitriol, as has been reported for
roid cell proliferation by calcitriol. The results obtained the activity of the 1-alpha-hydroxylase [13].
indicate that uremic toxins prevent the normal inhibition Other functions not directly related to calcium homeo-
of parathyroid cell proliferation by calcitriol. stasis have been shown to be altered by uremic toxins
such as the case of the CTR-induced monocyte CD14The action of CTR on target cells is mediated through
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expression [8], the platelet-activating factor (PAF) syn- duced by this high concentration of calcitriol. These find-
ings suggest that the potent inhibitory effects of uremicthesis by phagocytic leukocytes, which was abolished by
UUF in vitro [14] and the activity of erythrocyte Ca2- ultrafiltrates could result either from the additive effects
from the different toxins or from the supraphysiologicalATPase [15].
The present study evaluates, to our knowledge for the concentrations used for these in vitro tests, which could
limit any extrapolation to the in vivo situation.first time, a direct effect of uremic toxins on the parathy-
roid glands. The experiments were performed in vitro To identify uremic toxins that directly affect the inhibi-
tion of parathyroid cell proliferation by calcitriol, experi-using parathyroid tissue, which permits an evaluation of
an independent effect of uremic toxins and calcitriol on ments were performed with specific chemically pure
compounds that coelute with the different fractionsthe regulation of parathyroid cell cycle. The administra-
tion of calcitriol to animals would have resulted in an tested. Uric acid, indoxyl sulfate, phenol and p-cresol,
which coeluted with F1, F2, F3 and F4, respectively, wereincrease in calcium, which has separate effects on para-
thyroid cells. We used parathyroid tissue rather than assayed at the concentration range observed in vivo in
the uremic serum. All of them showed an effect similarisolated parathyroid cells because our previous study
using the same in vitro model showed an in vitro regula- to that observed with the corresponding HPLC-derived
fraction. Thus, phenol (eluting with F3) was the com-tion of parathyroid cell cycle by calcitriol [3]. Our present
study analyzed the CaR content of the parathyroid tissue pound that blocked the inhibitory effect of CTR on the
parathyroid cell proliferation. Phenol has been shown toslices maintained in vitro for 24 hours by Western blot-
ting, and showed a conserved expression of this receptor be elevated in the serum of uremic patients undergoing
hemodialysis in the concentration range used in our cur-in this model in which the architecture of the tissue was
maintained. In addition, in that same model we have rent study [18]. In a different in vitro model, F1 and F3
impaired the CTR-induced monocyte CD14 expressionevidenced that after a 24-hour incubation the changes
in extracellular calcium induced the appropriate varia- [8]; purine derivatives (uric acid, xhantine and hypoxhan-
tine), which coelute within F1, were found to suppresstion in PTH release (data not shown). The conservation
of the expression of CaR has been reported also in long- basal as well as CTR-induced CD14 expression of mono-
cytes. Phenol and p-cresol, with similar elution patternterm parathyroid cultures from human hyperplastic glands
that maintained the tissue architecture as tissue clusters as fractions F3 and F4, inhibited PAF synthesis by phago-
cytic leukocytes [14]. As compounds purified from UUF[16]. The requirement of maintaining an intact tissue
architecture suggests the involvement of cell-cell interac- have different chemical properties (ranging from the most
hydrophilic to the most hydrophobic HPLC-derived frac-tions or paracrine effects on the parathyroid function,
as has been demonstrated by confocal microscopy [17]. tions), some specific affinity must exist for different cell
types and functions. Accordingly, regarding the calcitriol-Our results showed that culture of parathyroid tissue
with total UUF or with each of the four HPLC-derived regulated functions, Hsu and Patel reported that the in-
hibitory effect of UUF on the formation of a VDR-fractions did not directly enhance the parathyroid cell
proliferation. Separate experiments were performed to RXR-DNA complex is due to a modification on the
VDR, not in the RXR [19]; the alteration of other nu-evaluate the ability of calcitriol to decrease the parathy-
roid cell proliferation in the presence of uremic ultrafila- clear receptors cannot be excluded, which could involve
some specificity to the toxic effect of uremic toxins.trate. While calcitriol (108 or 107 mol/L) reduces the
number of parathyroid cells entering the S phase of the In hyperplastic parathyroid tissue from patients with
advanced secondary hyperparathyroidism we have pre-cell cycle, the addition of total uremic ultrafiltrate pre-
vented this effect. The maximal concentration of calcitriol viously observed that 108 mol/L of calcitriol was unable
to decrease the parathyroid cell proliferation; however,used in the present study was 107 mol/L; higher concen-
trations of calcitriol would have been of little physiologi- 107 mol/L reduced the parathyroid cell proliferation to
60% of controls. By contrast, in normal dog parathyroidcal relevance.
The effects of the different HPLC-derived UUF frac- tissue a calcitriol concentration ranging from 1011 to
107 mol/L decreased cell proliferation in a concentra-tions on the inhibition of parathyroid cell cycle by calcitriol
also were analyzed. Fractions 1 to 3 impeded the normal tion dependent manner [3]. In the present study, experi-
ments were performed in normal parathyroid tissue ininhibition of parathyroid cell proliferation induced by a
108 mol/L concentration of calcitriol. Interestingly, the which an inhibition of cell proliferation by calcitriol is
observed; however, the addition of total UUF and theaddition of F4 (which contains indole –3 acetic acid,
p-cresol and CMPF) to the medium did not interfere with HPLC-derived fractions F1, F2 and F3 (but not F4) fully
abolished the inhibitory effect of calcitriol 108 mol/L.the regulation of parathyroid cell cycle by calcitriol. When
calcitriol concentration in the medium was increased to Furthermore, total UUF and F3 prevented the action of
calcitriol even at a concentration of 107 mol/L. The107 mol/L, only F3 (which contains phenol) was able
to prevent the inhibition of parathyroid cell cycle in- impairment of the effect of calcitriol on parathyroid cell
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proto-oncogene expression in primary cultures of bovine parathy-proliferation caused by uremic toxins, particularly phe-
roid cells. Endocrinology 125:935–941, 1989
nol, should not be considered as marginal, as this concen- 3. Canalejo A, Almaden Y, Torregrosa V, et al: The in vitro effect
of calcitriol on parathyroid cell proliferation and apoptosis. J Amtration of calcitriol was able to inhibit cell proliferation
Soc Nephrol 11:1865–1872, 2000in the hyperplastic parathyroid glands in vitro [3]. 4. Fukuda N, Tanaka H, Tominaga Y, et al: Decreased 1,25-dihy-
There are important clinical considerations that are droxyvitamin D3 receptor density is associated with a more severe
form of parathyroid hyperplasia in chronic uremic patients. J Clinderived from the results of the present study. Uremia
Invest 92:1436–1442, 1993itself independently of the serum concentration of cal- 5. Patel S, Ke HQ, Vanholder R, Hsu CH: Inhibition of nuclear
uptake of calcitriol receptor by uremic ultrafiltrate. Kidney Intcium, phosphate and calcitriol may play a role in the
46:129–133, 1994genesis of the hyperplasia secondary to renal failure.
6. Patel SR, Ke HQ, Vanholder R, et al: Inhibition of calcitriol
Therefore, treatment of uremia itself should improve receptor binding to vitamin D response elements by uremic toxins.
J Clin Invest 96:50–59, 1995the response of the parathyroid cells to the available
7. Hsu CH, Patel SR: Altered vitamin D metabolism and receptorcalcitriol concentration that is decreased in renal failure. interaction with the target genes in renal failure: calcitriol receptor
Fractions 1 and 2 contain essentially soluble compounds interaction with its target gene in renal failure. Curr Opin Nephrol
Hipertens 4:302–306, 1995that are easily removed by all of the presently available
8. Glorieux G, Hsu HC, De Smet R, et al: Inhibition of calcitriol-
dialysis systems. According to the present data, this re- induced monocyte CD14 expression by uremic toxins: Role of
purines. J Am Soc Nephrol 9:1826–1831, 1998moval should be optimized to allow an optimal impact
9. Vindelov LL, Christensen IJ: Detergent and proteolytic enzyme-of calcitriol on the parathyroid glands. F3 contains lipo- based techniques for nuclear isoltation and DNA content analysis.
philic compounds for which the available removal meth- Methods Cell Biol 41:219–229, 1994
10. Hsu HC, Patel SR, Vanholder R: Mechanism of decreased intes-ods are less efficient [20]. Therefore, to obtain an optimal
tinal calcitriol receptor concentration in renal failure. Am J Physiol
effect, we believe that our concept of dialysis should be 264:F662–F669, 1993
11. Toell A, Dehenhardt S, Grabensee R, Carlberg C: Inhibitorymodified in a way that lipophilic compounds, with a
effect of uremic solutions on protein-DNA-complex formation ofspecial mention on phenolic compounds, are efficiently
the vitamin D receptor and other members of the nuclear receptor
removed also. superfamily. J Cell Biochem 74:386–394, 1999
12. Inaba M, Okuno S, Koyama H, et al: Effect of uremic serum onIn conclusion, the present study demonstrates that
1,25-dihydroxyvitamin D3-induced differentiation of human pro-uremic toxins affect the inhibition of parathyroid cell myelocytic leukemia cell, HL-60. Nephron 63:152–158, 1993
13. Hsu CH, Patel S: Uremic plasma contains factors inhibiting 1proliferation induced by calcitriol.
alpha-hydroxylase activity. J Am Soc Nephrol 3:947–952, 1992
14. Wratten ML, Tetta C, De Smet R, et al: Uremic ultrafiltrate
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